A team of researchers from George Mason University published a study analyzing Komodo dragon blood. The group was able to successfully sequence 48 potential so-called CAMPs (cationic antimicrobial peptides), from which eight were selected and tested against human pathogens Pseudomonas aeruginosa and Staphylococcus aureus.